Asset Details
Do you wish to reserve the book?
Pointwise Hypothesis Testing of Biomedical Near-Infrared Spectroscopy Signals
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Pointwise Hypothesis Testing of Biomedical Near-Infrared Spectroscopy Signals
Do you wish to request the book?
Pointwise Hypothesis Testing of Biomedical Near-Infrared Spectroscopy Signals
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Pointwise Hypothesis Testing of Biomedical Near-Infrared Spectroscopy Signals
2025
Overview
This study uses a pointwise statistical approach to analyze Near-Infrared Spectroscopy (NIRS) signals in preterm infants with and without Patent Ductus Arteriosus (PDA). The analysis focuses on three signals: blood oxygenation (SpO2), cerebral oxygenation (rSO2-1), and renal oxygenation (rSO2-2), across three newborn groups: without PDA (no-PDA), with hemodynamically insignificant PDA (PDA), and with hemodynamically significant PDA (hsPDA). While NIRS is widely used in medicine, its research, featuring statistical analysis, has been limited. Smoothed signals were tested using pointwise ANOVA and Tukey HSD to detect significant group differences. Results showed distinct patterns in rSO2-1 and rSO2-2, with the hsPDA group standing out in rSO2-1 and the no-PDA group in rSO2-2, demonstrating the value of this method in biomedical signal analysis. Pointwise ANOVA shows more time periods with significant differences compared to the SpO2 signal. The time period with the most significant differences is between 2 and 6 h, with additional peaks of p-values below 0.05 occurring before 2 h. These findings demonstrate the value of FDA in improving statistical analysis of biomedical NIRS signals and support its use in future research.
Publisher
MDPI AG
